Malignant hyperthermia 2020: Guideline from the Association of Anaesthetists.
Hopkins PM, Girard T, Dalay S, Jenkins B, Thacker A, Patteril M, McGrady E.
Anaesthesia. 2021 May;76(5):655-664. doi: 10.1111/anae.15317. Epub 2021 Jan 5.
Malignant Hyperthermia: A Clinical Review.
Kim KSM, Kriss RS, Tautz TJ.
Adv Anesth. 2019 Dec;37:35-51. doi: 10.1016/j.aan.2019.08.003. Epub 2019 Sep 27.
Malignant hyperthermia.
Miranda AD, Donovan LA, Schuster LL, Gerber DR.
Am J Crit Care. 1997 Sep;6(5):368-74; quiz 375-6.
Malignant Hyperthermia: A Review.
Mullins MF.
J Perianesth Nurs. 2018 Oct;33(5):582-589. doi: 10.1016/j.jopan.2017.04.008. Epub 2017 Aug 25.
Nanoparticle-Mediated Hyperthermia and Cytotoxicity Mechanisms in Cancer.
Bala VM, Lampropoulou DI, Grammatikaki S, Kouloulias V, Lagopati N, Aravantinos G, Gazouli M.
Int J Mol Sci. 2023 Dec 25;25(1):296. doi: 10.3390/ijms25010296.
Malignant hyperthermia.
Marmor M.
Surv Ophthalmol. 1983 Sep-Oct;28(2):117-27. doi: 10.1016/0039-6257(83)90081-4.
Malignant hyperthermia.
Tomarken JL, Britt BA.
Ann Emerg Med. 1987 Nov;16(11):1253-65. doi: 10.1016/s0196-0644(87)80235-4.
Consensus guidelines on perioperative management of malignant hyperthermia suspected or susceptible patients from the European Malignant Hyperthermia Group.
Rüffert H, Bastian B, Bendixen D, Girard T, Heiderich S, Hellblom A, Hopkins PM, Johannsen S, Snoeck MM, Urwyler A, Glahn KPE; European Malignant Hyperthermia Group.
Br J Anaesth. 2021 Jan;126(1):120-130. doi: 10.1016/j.bja.2020.09.029. Epub 2020 Oct 31.
What is malignant hyperthermia susceptibility?
Hopkins PM.
Br J Anaesth. 2023 Jul;131(1):5-8. doi: 10.1016/j.bja.2023.04.014. Epub 2023 May 15.
Advanced patient-specific hyperthermia treatment planning.
Gavazzi S, van Lier ALHMW, Zachiu C, Jansen E, Lagendijk JJW, Stalpers LJA, Crezee H, Kok HP.
Int J Hyperthermia. 2020;37(1):992-1007. doi: 10.1080/02656736.2020.1806361.
